Specifically, cases of anti-HAV IgM positivity have been reported in patients with drug-induced hepatitis, autoimmune hepatitis (AIH), or AIH/primary biliary cholangitis (PBC) overlap syndrome. This evidence concerns the gene CD40LG and connective tissue disorder.